logo

Alnylam Pharmaceuticals Inc. (ALNY)



Trade ALNY now with
  Date
  Headline
12/15/2017 7:02:44 AM Alnylam And Sanofi Genzyme Announce That FDA Lifted Hold On Clinical Studies With Fitusiran
12/12/2017 7:01:12 AM Alnylam Completes Submission Of NDA To US FDA For Patisiran For Treatment Of Hereditary ATTR Amyloidosis
12/11/2017 7:02:51 AM Alnylam Pharma Says FDA Grants A Request To Amend The Orphan Drug Designation For Patisiran To ATTR Amyloidosis
11/20/2017 7:01:27 AM FDA Grants Alnylam BTD For Patisiran For HATTR Amyloidosis With Polyneuropathy
11/16/2017 7:06:53 AM Alnylam Initiates Rolling Submission Of NDA To FDA For Patisiran For Hereditary ATTR Amyloidosis
11/13/2017 8:08:49 PM Alnylam Prices Registered Public Offering Of 5.60 Mln Shares At $125.00/shr
11/13/2017 7:33:03 AM EMA Grants Alnylam Accelerated Assessment Of Patisiran For Patients With Hereditary ATT) Amyloidosis
11/13/2017 7:01:24 AM Alnylam Pharma Announces Proposed Public Offering Of $675 Mln Of Common Stock